182 related articles for article (PubMed ID: 25295578)
1. Effect of lanthanum carbonate versus calcium-based phosphate binders in dialysis patients: a meta-analysis.
Zhai CJ; Yu XS; Sun QL; Li L; Zhang LT; Zhou AY; Wang R
Clin Nephrol; 2014 Dec; 82(6):372-8. PubMed ID: 25295578
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
Zhai CJ; Yang XW; Sun J; Wang R
Int Urol Nephrol; 2015 Mar; 47(3):527-35. PubMed ID: 25399356
[TBL] [Abstract][Full Text] [Related]
3. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
[TBL] [Abstract][Full Text] [Related]
4. Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
Toida T; Fukudome K; Fujimoto S; Yamada K; Sato Y; Chiyotanda S; Kitamura K
Clin Nephrol; 2012 Sep; 78(3):216-23. PubMed ID: 22874110
[TBL] [Abstract][Full Text] [Related]
5. Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials.
Wang F; Lu X; Zhang J; Xiong R; Li H; Wang S
Kidney Blood Press Res; 2018; 43(2):536-544. PubMed ID: 29627829
[TBL] [Abstract][Full Text] [Related]
6. The effects of non-calcium-based phosphate binders versus calcium-based phosphate binders on cardiovascular calcification and bone remodeling among dialysis patients: a meta-analysis of randomized trials.
Liu L; Wang Y; Chen H; Zhu X; Zhou L; Yang Y
Ren Fail; 2014 Sep; 36(8):1244-52. PubMed ID: 25019348
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of phosphate binders lanthanum carbonate versus sevelamer hydrochloride in patients with end-stage renal disease undergoing hemodialysis.
Zhou T; Li H; Xie W; Lin Z
Afr Health Sci; 2018 Sep; 18(3):689-696. PubMed ID: 30603002
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.
Habbous S; Przech S; Acedillo R; Sarma S; Garg AX; Martin J
Nephrol Dial Transplant; 2017 Jan; 32(1):111-125. PubMed ID: 27651467
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-efficacy of phosphate binders in hemodialysis.
Brunner-Ziegler S; Fröschl B; Hiebinger C; Zsifkovits J
Ann Nutr Metab; 2011 Oct; 58(4):315-9. PubMed ID: 21986491
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.
Toussaint ND; Lau KK; Polkinghorne KR; Kerr PG
Nephrology (Carlton); 2011 Mar; 16(3):290-8. PubMed ID: 21342323
[TBL] [Abstract][Full Text] [Related]
11. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
Navaneethan SD; Palmer SC; Vecchio M; Craig JC; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2011 Feb; (2):CD006023. PubMed ID: 21328279
[TBL] [Abstract][Full Text] [Related]
12. Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study.
Ohtake T; Kobayashi S; Oka M; Furuya R; Iwagami M; Tsutsumi D; Mochida Y; Maesato K; Ishioka K; Moriya H; Hidaka S
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):439-46. PubMed ID: 23615577
[TBL] [Abstract][Full Text] [Related]
13. The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Jamal SA; Fitchett D; Lok CE; Mendelssohn DC; Tsuyuki RT
Nephrol Dial Transplant; 2009 Oct; 24(10):3168-74. PubMed ID: 19622572
[TBL] [Abstract][Full Text] [Related]
14. Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.
Palmer SC; Gardner S; Tonelli M; Mavridis D; Johnson DW; Craig JC; French R; Ruospo M; Strippoli GF
Am J Kidney Dis; 2016 Nov; 68(5):691-702. PubMed ID: 27461851
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for hyperphosphatemia.
Bellinghieri G; Santoro D; Savica V
Expert Opin Emerg Drugs; 2007 Sep; 12(3):355-65. PubMed ID: 17874966
[TBL] [Abstract][Full Text] [Related]
16. Effect of lanthanum carbonate on the progression of coronary artery calcification in hemodialysis patients: A meta-analysis of randomized controlled trials.
Xu JP; Zeng RX; Liao PD; Zhang MZ
Hemodial Int; 2022 Apr; 26(2):223-233. PubMed ID: 34897963
[TBL] [Abstract][Full Text] [Related]
17. Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Noto L
J Ren Nutr; 2011 May; 21(3):277-82. PubMed ID: 20598905
[TBL] [Abstract][Full Text] [Related]
18. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Patel L; Bernard LM; Elder GJ
Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
[TBL] [Abstract][Full Text] [Related]
19. The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.
Soriano S; Ojeda R; Rodríguez M; Almadén Y; Rodríguez M; Martín-Malo A; Aljama P
Clin Nephrol; 2013 Jul; 80(1):17-22. PubMed ID: 23391319
[TBL] [Abstract][Full Text] [Related]
20. Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA.
Sekercioglu N; Angeliki Veroniki A; Thabane L; Busse JW; Akhtar-Danesh N; Iorio A; Cruz Lopes L; Guyatt GH
PLoS One; 2017; 12(3):e0171028. PubMed ID: 28248961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
